Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference

Michael B. Atkins; Ronald M. Bukowski; Bernard J. Escudier; Robert A. Figlin; Gary H. Hudes; William G. Kaelin; W. Marston Linehan; David F. McDermott; James W. Mier; Ivan Pedrosa; Brian I. Rini; Sabina Signoretti; Jeffrey A. Sosman; Bin Tean Teh; Christopher G. Wood; Amado J. Zurita; Laura King

doi:10.1002/cncr.24229

Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference

Michael B. Atkins, Ronald M. Bukowski, Bernard J. Escudier, Robert A. Figlin, Gary H. Hudes, William G. Kaelin, W. Marston Linehan, David F. McDermott, James W. Mier, Ivan Pedrosa, Brian I. Rini, Sabina Signoretti, Jeffrey A. Sosman, Bin Tean Teh, Christopher G. Wood, Amado J. Zurita, Laura King

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Abstract

The Third Cambridge Conference on Innovations and Challenges in Renal Cancer, a symposium held in Cambridge, Massachusetts, June 27-28, 2008, and chaired by Michael B. Atkins, was convened to discuss the current state of knowledge in the field, critique new data, stimulate communication among those involved in basic and clinical research, and offer recommendations for further study. Four main topics were discussed: genetics and molecular biology of renal cell cancer, staging and prognosis, systemic therapy, and correlative science and biomarkers in stage IV disease. The conference format combined brief presentations with extended periods of discussion. The conclusions and recommendations are summarized in this paper and presented in more detail in the individual papers that follow.

Original language	English (US)
Pages (from-to)	2247-2251
Number of pages	5
Journal	Cancer
Volume	115
Issue number	SUPPL. 10
DOIs	https://doi.org/10.1002/cncr.24229
State	Published - May 15 2009

Keywords

Biomarkers
Genetics
Immunotherapy
Renal cancer
Vascular endothelial growth factor

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1002/cncr.24229

Cite this

Atkins, M. B., Bukowski, R. M., Escudier, B. J., Figlin, R. A., Hudes, G. H., Kaelin, W. G., Linehan, W. M., McDermott, D. F., Mier, J. W., Pedrosa, I., Rini, B. I., Signoretti, S., Sosman, J. A., Teh, B. T., Wood, C. G., Zurita, A. J., & King, L. (2009). Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference. Cancer, 115(SUPPL. 10), 2247-2251. https://doi.org/10.1002/cncr.24229

Atkins, MB, Bukowski, RM, Escudier, BJ, Figlin, RA, Hudes, GH, Kaelin, WG, Linehan, WM, McDermott, DF, Mier, JW, Pedrosa, I, Rini, BI, Signoretti, S, Sosman, JA, Teh, BT, Wood, CG, Zurita, AJ & King, L 2009, 'Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference', Cancer, vol. 115, no. SUPPL. 10, pp. 2247-2251. https://doi.org/10.1002/cncr.24229

@article{5c6ea503453d457ebca74ba16e14c2f6,

title = "Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference",

abstract = "The Third Cambridge Conference on Innovations and Challenges in Renal Cancer, a symposium held in Cambridge, Massachusetts, June 27-28, 2008, and chaired by Michael B. Atkins, was convened to discuss the current state of knowledge in the field, critique new data, stimulate communication among those involved in basic and clinical research, and offer recommendations for further study. Four main topics were discussed: genetics and molecular biology of renal cell cancer, staging and prognosis, systemic therapy, and correlative science and biomarkers in stage IV disease. The conference format combined brief presentations with extended periods of discussion. The conclusions and recommendations are summarized in this paper and presented in more detail in the individual papers that follow.",

keywords = "Biomarkers, Genetics, Immunotherapy, Renal cancer, Vascular endothelial growth factor",

author = "Atkins, {Michael B.} and Bukowski, {Ronald M.} and Escudier, {Bernard J.} and Figlin, {Robert A.} and Hudes, {Gary H.} and Kaelin, {William G.} and Linehan, {W. Marston} and McDermott, {David F.} and Mier, {James W.} and Ivan Pedrosa and Rini, {Brian I.} and Sabina Signoretti and Sosman, {Jeffrey A.} and Teh, {Bin Tean} and Wood, {Christopher G.} and Zurita, {Amado J.} and Laura King",

year = "2009",

month = may,

day = "15",

doi = "10.1002/cncr.24229",

language = "English (US)",

volume = "115",

pages = "2247--2251",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "SUPPL. 10",

}

TY - JOUR

T1 - Innovations and challenges in renal cancer

T2 - summary statement from the Third Cambridge Conference

AU - Atkins, Michael B.

AU - Bukowski, Ronald M.

AU - Escudier, Bernard J.

AU - Figlin, Robert A.

AU - Hudes, Gary H.

AU - Kaelin, William G.

AU - Linehan, W. Marston

AU - McDermott, David F.

AU - Mier, James W.

AU - Pedrosa, Ivan

AU - Rini, Brian I.

AU - Signoretti, Sabina

AU - Sosman, Jeffrey A.

AU - Teh, Bin Tean

AU - Wood, Christopher G.

AU - Zurita, Amado J.

AU - King, Laura

PY - 2009/5/15

Y1 - 2009/5/15

N2 - The Third Cambridge Conference on Innovations and Challenges in Renal Cancer, a symposium held in Cambridge, Massachusetts, June 27-28, 2008, and chaired by Michael B. Atkins, was convened to discuss the current state of knowledge in the field, critique new data, stimulate communication among those involved in basic and clinical research, and offer recommendations for further study. Four main topics were discussed: genetics and molecular biology of renal cell cancer, staging and prognosis, systemic therapy, and correlative science and biomarkers in stage IV disease. The conference format combined brief presentations with extended periods of discussion. The conclusions and recommendations are summarized in this paper and presented in more detail in the individual papers that follow.

AB - The Third Cambridge Conference on Innovations and Challenges in Renal Cancer, a symposium held in Cambridge, Massachusetts, June 27-28, 2008, and chaired by Michael B. Atkins, was convened to discuss the current state of knowledge in the field, critique new data, stimulate communication among those involved in basic and clinical research, and offer recommendations for further study. Four main topics were discussed: genetics and molecular biology of renal cell cancer, staging and prognosis, systemic therapy, and correlative science and biomarkers in stage IV disease. The conference format combined brief presentations with extended periods of discussion. The conclusions and recommendations are summarized in this paper and presented in more detail in the individual papers that follow.

KW - Biomarkers

KW - Genetics

KW - Immunotherapy

KW - Renal cancer

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=65949090273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65949090273&partnerID=8YFLogxK

U2 - 10.1002/cncr.24229

DO - 10.1002/cncr.24229

M3 - Article

C2 - 19402064

AN - SCOPUS:65949090273

SN - 0008-543X

VL - 115

SP - 2247

EP - 2251

JO - Cancer

JF - Cancer

IS - SUPPL. 10

ER -

Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this